Key indicators: single-crystal X-ray study; T = 296 K; mean (C-C) = 0.006 Å; R factor = 0.064; wR factor = 0.184; data-to-parameter ratio = 16.1.
Related literature
203 parameters H-atom parameters constrained Á max = 0.32 e Å À3 Á min = À0.37 e Å À3
Data collection: APEX2 (Bruker, 2009); cell refinement: SAINT (Bruker, 2009); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009). supplementary materials sup-1 . E68, o1356 supplementary materials . E68, o1356 [doi:10.1107 Considerable attention has been devoted to adamantane derivatives which have long been known for their diverse biological properties as antiviral against the influenza (Vernier et al., 1969) and HIV viruses (El-Emam, Al-Deeb, Al-Omar & Lehmann, 2004) . Moreover, adamantane derivatives were recently reported to exhibit marked antibacterial activity (Kadi et al., 2007 (Kadi et al., , 2010 . In continuation of our interest in the chemical and pharmacological properties of adamantane derivatives, we synthesized the title compound as a potential chemotherapeutic agent.
In the title molecule, Fig. 1 , the 1,2,4-triazole ring (N1-N3/C11/C12) is nearly planar with a maximum deviation of 0.005 (2) Å at atom N2. Bond lengths (Allen et al., 1987) and angles are within normal ranges and are comparable to those reported for related structures (Almutairi et al., 2012; Al-Tamimi et al., 2010; Al-Abdullah et al., 2012; Fun et al., 2011; Wang et al., 2011) . The crystal studied was a non-merohedral twin, the refined ratio of twin components being 0.281 (3):0.719 (3). There are no significant hydrogen bonds observed in this compound.
Experimental
A mixture of 3-(adamantan-1-yl)-4-methyl-4H-1,2,4-triazole-5-thiol (2.49 g, 0.01 mol), potassium hydroxide (1.12 g, 0.02 mol) and 2-dimethylaminoethyl chloride hydrochloride (1.44 g, 0.01 mol) in ethanol (15 ml) was heated under reflux with stirring for 3 h and the solvent was distilled off in vacuo. The obtained residue was washed with water and purified by column chromatography on silica gel column using CHCl 3 :MeOH (9:1 v/v) as eluent to yield 2.02 g (63%) of the title compound as colorless powder. M.p. 133-135°C. Single crystals suitable for X-ray diffraction were obtained by crystallization from aqueous ethanol. 1 H NMR (CDCl 3 , 500.13 MHz): δ 1.69-1.75 (m, 6H, adamantane-H), 2.04-2.85 (m, 9H, adamantane-H), 2.21 (s, 6H, 2xCH 3 ), 2.62 (t, 2H, CH 2 N, J = 6.5 Hz), 3.28 (t, 2H, SCH 2 , J = 6.5 Hz), 3.59 (s, 3H, CH 3 ). 13 
Refinement
All hydrogen atoms were positioned geometrically [C-H = 0.96-0.98 Å] and refined using a riding model, with U iso (H) = 1.2 or 1.5 U eq (C). A rotating group model was applied to the methyl groups. The crystal studied was a non-merohedral twin, the refined ratio of twin components being 0.281 (3):0.719 (3). 
Computing details

Figure 1
The molecular structure of the title compound showing 30% probability displacement ellipsoids for non-H atoms. Special details Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. Refinement. Refinement of F 2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The threshold expression of F 2 > 2sigma(F 2 ) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
2-{[5-(Adamantan-1-yl)-4-methyl-4H-1,2,4-triazol-3-yl]sulfanyl}-N,N-dimethylethanamine
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 )
x y z U iso */U eq S1 0.59451 (7) 0.30472 (8) 0.05471 (7) 0.0589 (3) (4) Geometric parameters (Å, º) S1-C12 1.742 (3) C13-C14 1.498 (6) S1-C13 1.811 (4) C13-H13A 0.9700 N1-C12 1.361 (4) C13-H13B 0.9700 N1-C11 1.384 (4) C2-C7 1.513 (7) N1-C17 1.455 (4) C2-C1 1.527 (5) N4-C16 1.421 (7) C2-H2A 0.9800 N4-C15 1.441 (6) C7-H7A 0.9700 N4-C14 1.464 (5) C7-H7B 0.9700 supplementary materials sup-5 . E68, o1356
C9-C11 1.495 (4) C1-H1A 0.9700 C9-C10 1.539 (5) C1-H1B 0.9700 C9-C1 1.542 (4) C8-H8A 0.9700 C9-C8 1.546 (5) C8-H8B 0.9700 C10-C6 1.531 (6) C11-N2 1.310 (4) C10-H10A 0.9700 N2-N3 1.390 (4) C10-H10B 0.9700 N3-C12 1.309 (4) C6-C5 1.508 (7) C14-H14A 0.9700 C6-C7 1.524 (7) C14-H14B 0.9700 C6-H6A 0.9800 C16-H16A 0.9600 C5-C4 1.524 (7) C16-H16B 0.9600 C5-H5A 0.9700 C16-H16C 0.9600 C5-H5B 0.9700 C17-H17A 0.9600 C4-C3 1.517 (7) C17-H17B 0.9600 C4-C8 1.531 (5) C17-H17C 0.9600 C4-H4A 0.9800 C15-H15A 0.9600 C3-C2 1.513 (7) C15-H15B 0.9600 C3-H3A 0.9700 C15-H15C 0.9600 C3-H3B 0.9700
